FIELD: medicine, pharmacy.
SUBSTANCE: composition comprises longolytin, acrylic acid and pyrrolidone copolymer, glycerol, polyethylene glycol, nipagin, heparin sodium and water wherein these components are taken in the definite ratio. Invention provides preparing the highly effective anti-thrombosis gel.
EFFECT: valuable medicinal properties of gel.
4 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN ARTHROBOTRYS LONGA MECHT AS PRODUCER OF LONGOLYTIN AND COMPLEX OF FIBRINOLYTIC AND THROMBOLYTIC ENZYMES WITH SPECIFIC CAPACITY TO ACTIVATE PLASMINOGEN AND EXTERNAL AGENT FOR THROMBOSIS TREATMENT | 2000 |
|
RU2182596C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VEIN DISEASES AND METHOD FOR ITS PREPARING | 2005 |
|
RU2299070C2 |
| DERMATAN SULFATE OR ITS SALT, ANTITHROMBOTIC AGENTS, METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS, METHOD OF PROPHYLAXIS OR TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME, METHOD OF MYOCARDIUM INFARCTION TREATMENT | 1994 |
|
RU2153506C2 |
| PHARMACEURICAL FORMULATION HAVING ANTICOAGULATIVE AND ANTIAGGREGATORY ACTION AND METHOD OF PRODUCTION | 2006 |
|
RU2326677C1 |
| ANTIVIRAL PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2538082C2 |
| USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS | 2021 |
|
RU2806093C1 |
| AGENT WITH ANTICOAGULATING EFFECT AND ITS APPLICATION METHOD | 2021 |
|
RU2799028C2 |
| STABILIZED STREPTOKINASE POSSESSING THROMBOLYTIC ACTIVITY | 0 |
|
SU822551A1 |
| MEDICATION, POSSESSING VENOMOTOR AND ANTICOAGULANT ACTION (VERSIONS) | 2012 |
|
RU2548785C2 |
| ANTI-INFLAMMATORY DIMEXID GEL | 2008 |
|
RU2408366C2 |
